Trileptal

Known as: Novartis brand of oxcarbazepine 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1994-2013
024619942013

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
A prospective non-randomized non-controlled multicenter trial has been conducted. The trial included 254 children, aged from 11… (More)
Is this relevant?
2006
2006
AIM Pharmacoeconomics comprises a system of relatively new methods that inform policy makers about the costs and benefits of… (More)
Is this relevant?
2005
2005
[reaction: see text] A new route to oxcarbazepine (Trileptal), the most widely prescribed antiepileptic drug, starting from… (More)
Is this relevant?
2002
2002
Twenty-five percent of epileptic patients present refractory seizures to current frontline antiepileptic drugs, needing new… (More)
Is this relevant?
Review
2002
Review
2002
Oxcarbazepine, although structurally similar to carbamazepine, is metabolised very differently. As a consequence, oxcarbazepine's… (More)
Is this relevant?
2001
2001
OBJECTIVE To evaluate the efficacy and safety of oxcarbazepine (OXC) as monotherapy for patients with uncontrolled partial… (More)
Is this relevant?
2001
2001
A high throughput preparation method for the determination of trileptal (oxcarbazepine, OXC) and its mono (MHD) and dihydroxy… (More)
Is this relevant?
2000
2000
Oxcarbazepin (10,11-dihydro-10-oxo-5H-dibenz-[b,f]azepin-5-carboxamid; OXC, Handelsname Trileptal®) ist ein neues Medikament zur… (More)
Is this relevant?
1994
1994
Oxcarbazepine (OCBZ, Trileptal) and its main human monohydroxy metabolite (MHD) protected mice and rats against generalized tonic… (More)
Is this relevant?
Review
1994
Review
1994
We report the clinical findings on all 260 epileptic in- and out-patients of a Dutch epilepsy centre ever treated with… (More)
Is this relevant?